Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy-Reference-Cited by-同舟云学术

Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy

Published:2022-12 Issue: Volume:186 Page:106536
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Cerqua Ida,Granato Elisabetta,Petti Antonio,Pavese Rocco,Costa Soraia Kátia Pereira,Feitosa Karla Barroso,Soares Antonio Garcia,Muscara Marcelo,Camerlingo Rosa,Rea Giuseppina,Fiorino Ferdinando,Santagada Vincenzo,Frecentese Francesco,Cirino Giuseppe,Caliendo Giuseppe,Severino Beatrice,Roviezzo Fiorentina

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. The management of severe asthma in 2020;Côté;Biochem. Pharmacol.,2020

2. The need for physiological phenotyping to develop new drugs for airways disease;David;Pharmacol. Res.,2020

3. Molecular and immunomodulatory actions of new antiasthmatic agents: exploring the diversity of biologics in Th2 endotype asthma;Okwuofu;Pharmacol. Res.,2022

4. Biologics or immunotherapeutics for asthma?;Tay;Pharmacol. Res.,2020

5. Why do some asthma patients respond poorly to glucocorticoid therapy?;Henderson;Pharmacol. Res.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma;Frontiers in Pharmacology;2023-10-12

2. Tingli Dazao Xiefei Decoction ameliorates asthma in vivo and in vitro from lung to intestine by modifying NO–CO metabolic disorder mediated inflammation, immune imbalance, cellular barrier damage, oxidative stress and intestinal bacterial disorders;Journal of Ethnopharmacology;2023-09